LGND
LIGAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$314.77
+0.40%Margins
Gross margin
107.1%
EBITDA margin
31.7%
EBIT margin
11.9%
Net margin
20.3%
FCF margin
35.7%
5.4%
Return on equity
2.3%
Return on assets
1.4%
Return on invested capital
0.11x
Asset turnover
$91.0M
Cash from operations
$22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026